Recovery of Bupivacaine or Bupivacaine-Lidocaine Spinal Anesthesia and Infiltration Anesthesia in Herniorrhaphy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01548794
Recruitment Status : Completed
First Posted : March 8, 2012
Last Update Posted : April 22, 2015
Information provided by (Responsible Party):
DILEK YAZICIOGLU, Diskapi Teaching and Research Hospital

Brief Summary:
The purpose of this study is the investigation of whether adding lidocaine to hyperbaric bupivacaine could decrease the duration of bupivacaine spinal block and provide shorter recovery and discharge times than local infiltration anesthesia in outpatient herniorrhaphy procedures.

Condition or disease Intervention/treatment Phase
Anesthesia Inguinal Hernia Procedure: spinal anesthesia Procedure: infiltration anesthesia Phase 4

Detailed Description:
Consecutive 93 patients undergoing inguinal herniorrhaphy will be recruited with a prospective protocol.Spinal anesthesia will be commenced in Group BLS with 2 ml hyperbaric bupivacaine (10 mg) + 0.6 ml 1 % lidocaine (6 mg), in Group BS, hyperbaric bupivacaine (10 mg) + saline in the same volume and Group LIA will have anesthesia with bupivacaine and lidocaine for step by step local anesthetic infiltration. Sensorial block will be measured with pinprick test, motor block will be tested with Bromage scale. Heart rate, blood pressure and peripheral oxygen saturation will be measured every 5 minutes. Time of subarachnoid injection, onset of sensorial block (block at L1 dermatome), time to block T10 dermatome, maximum block level, time to maximum block and time to two segment regression, T10 regression , LI regression and S1 regression of the block will be recorded in group BLS and BS.The onset and resolution of the sensorial and motor block will be assessed by anesthetists blinded to group allocation. PACU stay and discharge times and VAS pain scores will be recorded in all patients. Patients also will be investigated for adverse events (hypotension, bradycardia, nausea,PDPH, TNS, urinary retention)and satisfaction regarding the anesthetic method.

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 93 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Investigator)
Official Title: A Comparison of the Recovery Profiles of Bupivacaine or Bupivacaine Mixed With Lidocaine Spinal Anesthesia and Local Infiltration Anesthesia for Outpatient Herniorrhaphy
Study Start Date : March 2012
Actual Primary Completion Date : June 2012
Actual Study Completion Date : June 2012

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Anesthesia
U.S. FDA Resources

Arm Intervention/treatment
Active Comparator: Bupivacaine(Group B)
spinal anesthesia
Procedure: spinal anesthesia
To receive 2 ml heavy bupivacaine + 0,6 ml saline
Other Name: marcaine heavy
Experimental: Bupivacaine+Lidocaine (Group BL)
spinal anesthesia
Procedure: spinal anesthesia
To receive 2ml bupivacaine +0,6 ml 1% lidocaine for spinal anesthesia.
Other Names:
  • marcaine heavy
  • lidocaine
Active Comparator: Local Infitration Anesthesia(Group LI)
local infiltration anesthesia
Procedure: infiltration anesthesia
To receive step by step local infiltration anesthesia as described by the Lichtenstein Institute.
Other Names:
  • marcaine
  • lidocaine

Primary Outcome Measures :
  1. Duration of spinal block [ Time Frame: day of surgery ]
    Time between the onset of the sensorial block at L1 dermatome and the resolution of the sensorial block at S3 dermatome.

Secondary Outcome Measures :
  1. Discharge time [ Time Frame: Day of surgery ]
    The time between the end of surgery and home discharge.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   19 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patients having inguinal hernia
  • Not hypersensitive to study drugs
  • ASA classification I-III

Exclusion Criteria:

  • ASA classification IV-V
  • Contraindications for spinal anesthesia

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01548794

Diskapi Yildirim Beyazit Training and Research Hospital
Ankara, Turkey, 06610
Sponsors and Collaborators
Diskapi Teaching and Research Hospital
Principal Investigator: Dilek Yazicioglu

Responsible Party: DILEK YAZICIOGLU, Doctor Specialist in Anesthesiology Principal investigator, Diskapi Teaching and Research Hospital Identifier: NCT01548794     History of Changes
Other Study ID Numbers: DiskapiTRHDYAZICIOGLU
First Posted: March 8, 2012    Key Record Dates
Last Update Posted: April 22, 2015
Last Verified: December 2012

Keywords provided by DILEK YAZICIOGLU, Diskapi Teaching and Research Hospital:
spinal anesthesia
local infiltration anesthesia
duration of anesthesia
outpatient herniorrhaphy

Additional relevant MeSH terms:
Hernia, Inguinal
Hernia, Abdominal
Pathological Conditions, Anatomical
Central Nervous System Depressants
Physiological Effects of Drugs
Anesthetics, Local
Sensory System Agents
Peripheral Nervous System Agents
Anti-Arrhythmia Agents
Voltage-Gated Sodium Channel Blockers
Sodium Channel Blockers
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action